Case Report
Accepted on 13 Feb 2026
Efficacy of Sacituzumab govitecan in Triple-Negative Breast Cancer with Hepatic Visceral Crisis: a case report
in Breast Cancer
Frontiers in Oncology
- Frontiers in Oncology
- Breast Cancer
- Articles
Type at least 3 characters
1,693 articles
articles
Original Research
Accepted on 13 Feb 2026
Knowledge-Based Planning for Intensity-Modulated Proton Therapy of the Breast and Chest Wall with Regional Lymph Nodes: Development, Validation, and Comparative Evaluation of Two Models
in Breast Cancer
Frontiers in Oncology
Systematic Review
Accepted on 13 Feb 2026
Prevalence of Depression Among Breast Cancer Patients in Asia: A Systematic Review and Meta-Analysis
in Breast Cancer
Frontiers in Oncology
Original Research
Published on 13 Feb 2026
Uncovering potential molecular biomarkers for cancer-associated secondary lymphedema through integrated analyses of RNA-sequencing, machine learning, and clinical data
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1760040
- 284 views
Original Research
Published on 13 Feb 2026
Modified systemic immune-inflammatory index, modified systemic inflammatory response index and hemoglobin-albumin-lymphocyte-platelet score may serve as markers for evaluating the efficacy of neoadjuvant therapy in breast cancer patients
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1746164
- 242 views
Case Report
Published on 13 Feb 2026
Postoperative recurrence and systemic metastasis of large cell neuroendocrine carcinoma of the breast: a case report including T-DXd treatment
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1747084
- 214 views
Case Report
Published on 13 Feb 2026
Gardner syndrome initially misdiagnosed as bilateral breast malignancy: a case report and literature review
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1691293
- 237 views
Original Research
Accepted on 12 Feb 2026
Disorder of the immune and inflammatory response involving galectin-1, -3 and -7 in women with invasive breast cancer – potential importance in diagnosis and monitoring the course of the disease
in Breast Cancer
Frontiers in Oncology
Case Report
Accepted on 12 Feb 2026
Breast metastasis from biliary tract cancer: a rare case and literature review
in Breast Cancer
Frontiers in Oncology
Original Research
Accepted on 12 Feb 2026
PI3K/AkT/mTOR Pathway Expression Profiling Reveals Age-and Subtype-Specific Molecular Heterogeneity in the Nigerian Breast Cancer Landscape
in Breast Cancer
Frontiers in Oncology
Correction
Published on 11 Feb 2026
Correction: Beyond surface dose: subcutaneous dose escalation underlies TomoTherapy’s skin toxicity in breast radiotherapy
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1796339
- 264 views
Original Research
Accepted on 10 Feb 2026
Symptom Networks in Breast Cancer Patients During Chemotherapy and Their Impact on Daily Living Status
in Breast Cancer
Frontiers in Oncology
- 175 views
Original Research
Accepted on 10 Feb 2026
Analysis of PIK3CA mutations in the lysate of sentinel lymph nodes in patients with early breast cancer
in Breast Cancer
Frontiers in Oncology
- 154 views
Original Research
Accepted on 10 Feb 2026
Trastuzumab Deruxtecan in Advanced Breast Cancer: A Real-World Study of Efficacy and Safety in Chinese Cohort with HER2-Positive and HER2-Low Expression
in Breast Cancer
Frontiers in Oncology
Perspective
Accepted on 09 Feb 2026
Non-Invasive Lymphatic MRI as a Potential Alternative to Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: A Perspective
in Breast Cancer
Frontiers in Oncology
- 167 views
Original Research
Accepted on 09 Feb 2026
Development and Validation of a Pathomics-driven Machine Learning Model for Individualized Prediction of Neoadjuvant Chemotherapy Response and Early Recurrence in HR-positive, HER2-negative Breast Cancer
in Breast Cancer
Frontiers in Oncology
Original Research
Accepted on 09 Feb 2026
Real-world effectiveness and safety of Sacituzumab Govitecan in metastatic triple-negative breast cancer: Results from the multicenter retrospective observational SACISUR cohort in Southern Spain
in Breast Cancer
Frontiers in Oncology
Opinion
Accepted on 09 Feb 2026
Critical Considerations for the Use of Deep Learning Models in Clinical Oncology Prediction
in Breast Cancer
Frontiers in Oncology
- 287 views
Case Report
Accepted on 09 Feb 2026
Case Report: Long-Term Survival of a Male Patient with Breast Cancer Complicated by Lung Adenocarcinoma Treated with Individualized Therapy
in Breast Cancer
Frontiers in Oncology
Original Research
Accepted on 09 Feb 2026
BRCA Genetic Testing and Treatment Patterns for Patients With HER2-Negative Early-Stage Breast Cancer in the US Community Setting
in Breast Cancer
Frontiers in Oncology
Review
Accepted on 09 Feb 2026
Gut Microbiota-Regulated Tryptophan Metabolism in Breast Cancer: Mechanisms and Therapeutic Perspectives
in Breast Cancer
Frontiers in Oncology
Original Research
Accepted on 09 Feb 2026
Risk Prediction Model for Radiation Pneumonitis in Breast Cancer Radiotherapy Based on Dose–Volume Parameters Combined with the Neutrophil-to-Lymphocyte Ratio
in Breast Cancer
Frontiers in Oncology
Original Research
Published on 09 Feb 2026
Bisphosphonates in breast cancer radiotherapy: associations with skeletal complications and treatment outcomes - a retrospective cohort study
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1725699
- 644 views
Editorial
Published on 09 Feb 2026
Editorial: Molecular and functional profiling in breast cancer: implications for hereditary and sporadic cases
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1773220
- 306 views